Filing Details
- Accession Number:
- 0001237648-20-000071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-30 15:56:22
- Reporting Period:
- 2020-11-27
- Accepted Time:
- 2020-11-30 15:56:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1038133 | Heska Corp | HSKA | In Vitro & In Vivo Diagnostic Substances (2835) | 770192527 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1737532 | D Jason Aroesty | 3760 Rocky Mountain Avenue Loveland CO 80538 | Evp, International Diagnostics | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-27 | 11,460 | $106.67 | 11,460 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-11-27 | 1,874 | $106.67 | 13,334 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-27 | 10,233 | $126.68 | 3,101 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-27 | 3,101 | $127.44 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2020-11-27 | 1,874 | $0.00 | 1,874 | $106.67 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-27 | 11,460 | $0.00 | 11,460 | $106.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
937 | 2018-07-25 | 2028-07-24 | No | 4 | M | Direct |
5,729 | 2018-07-25 | 2028-07-24 | No | 4 | M | Direct |
Footnotes
- The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.16 to $127.15. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected
- The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.16 to $127.855. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected